Cipherome operates in the healthcare and biotechnology sectors, focusing on leveraging artificial intelligence (AI) to enhance data analysis and research capabilities. The company serves healthcare providers, researchers, and pharmaceutical companies by offering a comprehensive data analysis platform known as COMPASS. This platform enables users to train AI models effortlessly, conduct statistical tests without coding, and define patient cohorts with precision. By automating tasks such as summarizing lengthy documents and generating social media posts, Cipherome aims to accelerate the research process and improve evidence-based decision-making. The business model is primarily subscription-based, generating revenue through platform access fees and premium features. Cipherome's market includes academic institutions, clinical research organizations, and biotech firms looking to optimize their data-driven research efforts.

Keywords: AI, data analysis, healthcare, predictive analytics, cohort querying, research efficiency, machine learning, clinical research, biotechnology, COMPASS platform.